mifepristone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giefing, M; Jin, J; Klapper, W; Krams, M; Krause, K; Ma, L; Siebert, R; Sotnikova, A; Szczepanowski, M; Xu, G | 1 |
1 other study(ies) available for mifepristone and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma.
Topics: Apoptosis; Cell Line, Tumor; Flow Cytometry; Gene Expression Regulation; Guanine Nucleotide Dissociation Inhibitors; Hodgkin Disease; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Mifepristone; Reed-Sternberg Cells; Reverse Transcriptase Polymerase Chain Reaction; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho Guanine Nucleotide Dissociation Inhibitor beta; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Transfection; Transgenes; Tumor Suppressor Proteins | 2007 |